Elucidating the specific pharmacological system of action (MOA) of naturally happening compounds might be tough. Whilst Tarselli et al. (60) designed the main de novo synthetic pathway to conolidine and showcased this The natural way occurring compound successfully suppresses responses to the two chemically induced and inflammation-derived pain, th